A Pilot Study of KPL-914 in Recurrent Pericarditis

Completed · Phase 2

Conditions studied: Recurrent Pericarditis

In brief

The purpose of this study is to assess the preliminary efficacy and safety of KPL-914 treatment in participants with recurrent pericarditis.

Key facts

Study ID

NCT03980522

Run by

Kiniksa Pharmaceuticals (UK), Ltd.

People needed

26

Starts

2018-01-24

Expected to finish

2019-05-17

Last updated by the study team

2021-05-27

Who can join

Age: 6 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Medstar Washington Hospital Center — Washington D.C., District of Columbia, United States
• Avail Clinical Research, LLC — DeLand, Florida, United States
• Mayo Clinic Jacksonville — Jacksonville, Florida, United States
• Affinity Clinical Research Institute — Oak Brook, Illinois, United States
• Franciscan Physician Network Indiana Heart Physicians Cardiovascular Research Program — Indianapolis, Indiana, United States
• Research Integrity, LLC — Owensboro, Kentucky, United States
• Minneapolis Heart Institute Foundation — Minneapolis, Minnesota, United States
• Mayo Clinic — Rochester, Minnesota, United States
• Ellipsis Research Group — Brooklyn, New York, United States
• Cleveland Clinic — Cleveland, Ohio, United States
• BI Research Center — Houston, Texas, United States
• University of Vermont Medical Center — Burlington, Vermont, United States
• Virginia Commonwealth University — Richmond, Virginia, United States
• Swedish Medical Center — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.